Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Notice of Results

28th Feb 2020 07:00

RNS Number : 3857E
Intelligent Ultrasound Group PLC
28 February 2020
 

Intelligent Ultrasound Group plc

("the Company")

 

Notice of Results

Analyst briefing

 

Intelligent Ultrasound Group plc (LSE: MED), the ultrasound artificial intelligence (AI) software and simulation company, announces it will issue its final results for the year ended 31 December 2019 on Thursday, 26 March 2020.

 

The Company will host a briefing for analysts at the offices of Walbrook PR, 4 Lombard Street, London EC3V 9HD at 9.30am on Thursday, 26 March. If you would like to register to attend the analyst briefing or require further information, please contact Walbrook PR on 020 7933 8780 or email [email protected]. 

 

For further information, please contact:

 

Intelligent Ultrasound Group plc 

www. intelligentultrasound.com

Stuart Gall, CEO Helen Jones, Group Finance Director

Tel: +44 (0)29 2075 6534 

Cenkos Securities - Nominated Advisor and Broker

Tel: +44 (0)20 7397 8900 

Giles Balleny / Cameron MacRitchie (Corporate Finance)

Michael Johnson / Julian Morse (Sales) 

Walbrook PR 

Tel: +44 (0)20 7933 8780 or [email protected] 

Anna Dunphy / Paul McManus 

Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893

 

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: MED) develops artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market and hi-fidelity virtual reality simulators for the ultrasound training market.

Based in Cardiff and Oxford in the UK, Atlanta in the US and with representation in Beijing in Asia, the Group operates two divisions:

Clinical AI Division

Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible. Products in development include ScanNav which uses machine-learning based algorithms to automatically identify and grade ultrasound images to provide scan assessment and audit of protocol-based ultrasound scanning; and AnatomyGuide, which aims to simplify ultrasound-guided needling by providing the user with real-time AI-based needle guidance software for a range of medical procedures.

 

Simulation Division

Focusses on hi-fidelity ultrasound education and training through simulation. Its three main products are the ScanTrainer OBGYN training simulator, the HeartWorks echocardiography training simulator and the BodyWorks Eve Point of Care and Emergency Medicine training simulator. To date over 800 simulators have been sold to almost 500 medical institutions around the world.

 

www.intelligentultrasound.com 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NORZZGZZFNZGGZM

Related Shares:

MED.L
FTSE 100 Latest
Value8,809.74
Change53.53